Advances in Multiple Sclerosis Research to be Presented at Meeting Hosted by Yale and Veterans
Research aimed at finding new drug therapies for the paralysis, loss of vision, pain and other symptoms related to multiple sclerosis will be presented in a meeting on April 17 at the Veterans Administration Medical Center in West Haven.
The event will be hosted by the Paralyzed Veterans of America (PVA) in association with the PVA/Eastern PVA (EPVA) Center for Neuroscience and Regeneration Research at Yale University. It is intended to coincide with PVA Awareness Week.
PVA Awareness Week seeks to increase public awareness of its mission to serve veterans with disabilities, especially those with spinal cord injuries and multiple sclerosis. The PVA is a congressionally chartered veterans service organization and a strong advocate for many issues related to individuals with disabilities, including research and education in the area of spinal cord disorders.
“This event provides an excellent opportunity for individuals with interest in multiple sclerosis to learn more about the cutting edge research on functional restoration through cell transplantation, neuropathic pain, neuroprotection and identification of therapeutic targets that will permit more effective treatment of symptoms such as paralysis, loss of vision, and pain in multiple sclerosis,” said Steven Waxman, M.D., chair of the Department of Neurology at Yale School of Medicine.
The PVA funded the construction of the PVA/EPVA Center at Yale in 1988 and continues to provide funds for research, equipment, training and education within the center.
The meeting will be held from noon to 3 p.m. in Building 34 at the VA Medical Center in West Haven.